News

Novel SARS-CoV-2 vaccine program

Novel SARS-CoV-2 vaccine program 04/07/2020 Avidin´s novel SARS-CoV-2 vaccine program has been funded by National Research, Development and Innovation Office Project identification number: 2020-2.1.1.-ED-2020-00015Project title:

Research Grants

Market-leaded Research Development and Innovation Support

Avidin together with partner Synaptogenex awarded with Market-leaded Research Development and Innovation Support 20.01.2020 Project title: Development, testing and production of active compounds and functional

Research Grants

H2020 grant

PHC-14-2015 „Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion…

fp7
European

XENOISLET

FP7 grant “XENOISLET” Project full title: “Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2”…